Yoshimasa Kamei

Yoshimasa Kamei

Auto-generated profile, based on publicly available information

Yoshimasa Kamei

Department of Obstetrics and Gynecology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
AIAtsuo Itakura
Atsuo Itakura
SSShoji Satoh
Shoji Satoh
SAShigeru Aoki
Shigeru Aoki
KFKotaro Fukushima
Kotaro Fukushima
JHJunichi Hasegawa
Junichi Hasegawa
MSMakio Shozu
Makio Shozu

5 December 2021 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
STSHUNSUKE TAMARU
SHUNSUKE TAMARU
SJSeung Chik Jwa
Seung Chik Jwa
YOYoshihisa Ono
Yoshihisa Ono
HSHiroyuki Seki
Hiroyuki Seki
HMHaruka Matsui
Haruka Matsui
YKYoshimasa Kamei
Yoshimasa Kamei

11 September 2018 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
PDF file
KOKatsufumi Otsuki
Katsufumi Otsuki
IKIkuno Kawabata
Ikuno Kawabata
YMYoshio Matsuda
Yoshio Matsuda
ANAkihito Nakai
Akihito Nakai
NSNorio Shinozuka
Norio Shinozuka
TOTakashi Okai
Takashi Okai
Aim: To assess the preventive effect on preterm birth of intravaginal ulinastatin (urinary trypsin inhibitor; UTI) administration during the mid‐trimester in women with singleton pregnancy and both cervical shortening and lower genital infections.Methods: Pregnant women with a short cervical length < 25 mm between 16 and 26 weeks of gestation and who had been diagnosed with a lower genital infection were randomly assigned for intravaginal UTI administration or placebo. All of the women were screened for infection or inflammation of the lower genital tract, and women with negative results were excluded.Results: Of the 92 patients with a short cervical length who were assessed for eligibility for this study, 86 singleton patients were enrolled. All patients were randomized to one of two treatment groups: patients administered UTI (n = 35) and placebo (n = 35). There were no differences between the two groups in the incidence of preterm delivery before 28, 30, 32, 34 and 37 weeks of gestation and in perinatal outcomes.Conclusion: For women diagnosed with a short cervical length < 25 mm) between 16 and 26 weeks of gestation and lower genital infection, who were at risk of preterm birth, administration of transvaginal UTI with vaginal irrigation showed no apparent benefit. Future research on the efficacy of UTI should evaluate modified modes of UTI application.

30 October 2024 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
YAYohei Akazawa
Yohei Akazawa
SYSatoshi Yasukochi
Satoshi Yasukochi
KTKohta Takei
Kohta Takei
KTKiyohiro Takigiku
Kiyohiro Takigiku
NINoboru Inamura
Noboru Inamura
FGFetal HQ Study Group
Fetal HQ Study Group